Newstral
Hoffman La Roche
- Genentech, Inc. v. Sandoz, Inc. - Esbriet® (Pirfenidone)jdsupra.com
- EU and UK Consider First Stand-Alone Disparagement Casesjdsupra.com
- Fresenius Kabi’s Actemra® biosimilar Tyenne® (tocilizumab-aazg) Approved in the U.S.jdsupra.com
- Life Sciences Companies Make Up a Small Portion of the Companies Opting-In to the Unitary Patent; Ireland Announces Referendum Datejdsupra.com
- New BPCIA Case Filed: Genentech and Biogen Want to Stop Dr. Reddy’s Rituximab Biosimilar from Entering the U.S. Marketjdsupra.com
- In the Wake of the Supreme Court's Amgen v. Sanofi decision: What’s Next for Biotechnology Claims?jdsupra.com
- Uta G. Schenckysnews.com
- Competition Legal Quarters - Q2 2022jdsupra.com
- LCOVID19 Impact on Liver Cirrhosis Market 2021 Industry Insight and Growth Strategy by Business Playersliverpoolstudentmedia.com
- KOrgan Transplant Immunosuppressant Drugs Market: Pin-Point Analysis for Changing Competitive Dynamicsksusentinel.com
- 2021 Biosimilar Approval and Litigation Updatejdsupra.com
- Drugmaker from Japan relocating its N.J. workers to long-vacant sitenj.com
- Fifth Circuit Holds District Courts in FLSA Actions May Not Send Notice to Employees with Valid Arbitration Agreements that Prohibit Participation in a Collective Actionjdsupra.com
- Fifth Circuit Addresses Notices of Collective Action for Those Who Signed Arbitration Agreements Requiring Only Individual Claimsjdsupra.com
- Hoffman-La Roche Disclaims Patent Claims in Response to IPRjdsupra.com
- Celltrion, Inc. v. Genentech, Inc. (N.D. Cal. 2018)jdsupra.com
- PDeveloping the first effective drug for progressive MSpublications.mcgill.ca
- The World in U.S. Courts - Winter 2018jdsupra.com
- Proposed new medical school in N.J. clears a major hurdlenj.com
- Hallucinations After Taking Tamiflu: How Much Is Real Versus Not Real?Forbes
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.